Sartorius (FRA:SRT3) has been given a €60.00 ($71.43) target price by equities researchers at Hauck & Aufhaeuser in a research note issued on Wednesday. The firm presently has a “sell” rating on the stock. Hauck & Aufhaeuser’s price objective would indicate a potential downside of 31.03% from the stock’s current price.
SRT3 has been the subject of a number of other reports. Deutsche Bank set a €88.00 ($104.76) price objective on Sartorius and gave the stock a “neutral” rating in a research report on Tuesday, October 17th. Kepler Capital Markets set a €78.00 ($92.86) target price on Sartorius and gave the stock a “neutral” rating in a research report on Thursday, January 4th. Berenberg Bank set a €85.00 ($101.19) target price on Sartorius and gave the stock a “buy” rating in a research report on Wednesday, December 6th. UBS Group set a €85.00 ($101.19) target price on Sartorius and gave the stock a “neutral” rating in a research report on Tuesday, October 17th. Finally, Oddo Bhf set a €72.00 ($85.71) target price on Sartorius and gave the stock a “sell” rating in a research report on Tuesday, October 17th. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. Sartorius has a consensus rating of “Hold” and an average target price of €78.40 ($93.33).
Shares of Sartorius (SRT3) opened at €87.00 ($103.57) on Wednesday. The company has a market capitalization of $6,520.00 and a PE ratio of 70.73. Sartorius has a 12-month low of €63.72 ($75.86) and a 12-month high of €94.00 ($111.90).
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.com-unik.info/2018/01/10/sartorius-srt3-given-a-60-00-price-target-by-hauck-aufhaeuser-analysts.html.
Sartorius Aktiengesellschaft provides laboratory and process technologies and equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.
What are top analysts saying about Sartorius? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Sartorius and related companies.